Actively Recruiting
NIRS Monitoring in the NICU and AKI
Led by NYU Langone Health · Updated on 2025-10-30
100
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary objective of this study is to describe the pattern of renal tissue oxygen saturation (SrSO2) using near-infrared spectroscopy (NIRS) in premature infants \<30 weeks gestational age. The secondary objective of this study is to evaluate prenatal and postnatal risk factors for acute kidney injury (AKI) in premature infants \<30 weeks gestational age. The investigators will also compare various rates of complications including death, length-of-stay, and prolonged duration of mechanical ventilation, among others.
CONDITIONS
Official Title
NIRS Monitoring in the NICU and AKI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Any neonate less than 30 weeks in gestational age
- Willingness and capacity of both adult parents/guardians to sign consent
You will not qualify if you...
- Infant with known congenital kidney anomalies such as grade 4 or 5 vesicoureteral reflux, posterior urethral valves, moderate or severe hydronephrosis, autosomal recessive polycystic kidney disease, or bilateral renal agenesis or dysplasia
- Gestational age greater than 30 weeks
- Gestational age less than 24 weeks and weight less than 500 grams
- Clinician's decision that NIRS monitoring is unsuitable due to the patient's clinical condition
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYU Langone Health
New York, New York, United States, 10016
Actively Recruiting
Research Team
J
Jordan Nelson, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here